The decision comes after state health officials were worried that doses of the company’s coronavirus shots would expire and go to waste.
Tag: Drugs (Pharmaceuticals)
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests
Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses.
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccine
Federal regulators concluded that the risk of developing the syndrome was low, and that the benefits of the vaccine still strongly outweigh it.
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus.
As Lebanon’s Crisis Deepens, Lines for Fuel Grow, and Food and Medicine Are Scarce
The World Bank said the financial crisis could rank among the world’s three worst since the mid-1800s. The currency has lost more than 90 percent of its value and unemployment has skyrocketed.
Should People With Immune Problems Get Third Vaccine Doses?
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
Training the Next Generation of Indigenous Data Scientists
A new workshop explores the right of Indigenous people to govern the collection, ownership and use of their biological and cultural data.
Singapore Allows Sinovac Shots but Casts Doubt on Effectiveness
Singapore is allowing 24 private health clinics to administer the vaccine. But it has not added it to the national vaccination program.
High Hopes for Johnson & Johnson’s Covid Vaccine Have Fizzled in the U.S.
Production problems and a brief pause on its use kept the one-dose vaccine from becoming the game changer that health officials across the country believed it would be.
A U.N. Declaration on Ending AIDS Should Have Been Easy. It Wasn’t.
Even with U.N.’s previous goals unmet, delegates tried to water down provisions regarding protections for vulnerable populations and patents for essential drugs.